Alexo Therapeutics

June 4, 2018

Alexo Begins Testing ALX148 Combinations in Phase 1 Trial of NHL, Solid Tumors

News

Alexo Therapeutics has started treating patients in the combination part of its Phase 1 trial, which will test multiple combinations of ALX148 with targeted antibody therapies — including Keytruda (pembrolizumab), Herceptin ... Read more

April 11, 2017

Alexo Starts Phase 1 Clinical Trial of ALX148 for Solid Tumors and Lymphoma

News

Alexo Therapeutics has begun dosing patients in a Phase 1 clinical trial designed to evaluate the characteristics in the body and the safety of the CD47 inhibitor ALX148 in patients with advanced solid tumors and ... Read more